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Summary 
Nitric  oxide  (NO)-related  activity has been shown  to be protective  against  Plasmodium faki- 
parum in vitro.  It has been hypothesized, however,  that excess NO  production contributes to 
the pathogenesis of cerebral malaria. The purpose of this study was to compare markers of NO 
production [urinary and plasma nitrate  +  nitrite  (NO~)], leukocyte-inducible nitric oxide syn- 
thase type 2  (NOS2), and plasma TNF-c~ and IL-10 levels with disease severity in 191 Tanza- 
nian  children  with  and  without  malaria.  Urine  NO￿  excretion  and  plasma  NOx levels  (cor- 
rected  for renal  impairment)  were  inversely related  to disease  severity, with levels highest in 
subclinical infection and lowest in fatal cerebral malaria. Results could not be explained by dif- 
ferences  in  dietary  nitrate  ingestion  among the  groups.  Plasma  levels  of IL-10,  a  cytokine 
known  to  suppress  NO  synthesis,  increased  with  disease  severity.  Leukocyte NOS2  antigen 
was detectable in all control children tested and in all those with subclinical infection, but was 
undetectable  in all but one subject with cerebral malaria.  This suppression of NO  synthesis in 
cerebral malaria may contribute  to pathogenesis.  In contrast, high fasting NO x levels and leu- 
kocyte NOS2 in healthy controls and asymptomatic infection suggest that increased NO  syn- 
thesis might protect against clinical disease. NO appears to have a protective rather than patho- 
logical role in African children with malaria. 
M 
alaria continues to be a major cause of morbidity and 
mortality in  African  children,  being  responsible  for 
approximately 1-2 million deaths each year (1,  2). The na- 
ture of the protective in~nune response to Plasmodiumfalci- 
parum is not fully understood. Similarly unclear is the patho- 
genesis of cerebral malaria, a major cause of malaria mortality 
in Africa. Both parasite sequestration within cerebral blood 
vessels and cytokine-mediated immunopathology are thought 
to be important (3). 
Proinflammatory host cytokines such as TNF have pro- 
tective  antiparasitic  effects in vitro  (4).  There  is  evidence, 
however, that excessive TNF production contributes to the 
pathogenesis of cerebral malaria (CM1; 5-7). Because TNF 
is a potent inducer of inducible nitric oxide synthase type 2 
(NOS2)  (8-10), more recent interest has focused on a pos- 
sible  similar  dual  role  for  nitric  oxide  (NO)  in  malaria. 
NO-related  species  mediate  inhibition  of malaria  parasites 
by hepatocytes and  monocytes in vitro  (11-14).  The  role 
of NO in the human protective immune response to P. fal- 
ciparum in vivo, however, has not been determined.  Inves- 
tigators have hypothesized that in CM,  high local concen- 
trations  of  TNF  induce  excessive  synthesis  of  NO  in 
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Volume 184  August 1996  557-567 cerebrovascular  endothelial  cells,  and  that  this  NO  alters 
neurotransmission,  causing profound but reversible coma (15). 
NO  is  rapidly  oxidized  to  the  stable  inorganic  nitrogen 
oxides nitrite and nitrate in vivo (16,  17).  Measurement  of 
these  metabolites  has  been  used  to  demonstrate  cytokine- 
inducible  NO  synthesis  in humans  (18).  To assess the rela- 
tionship  between  NO  production  and  malaria  disease  se- 
verity,  we  prospectively  measured  NO  metabolites  and 
leukocyte NOS2  in five groups of Tanzanian  children with 
and  without  cerebral  malaria.  Our  results  indicate  that 
rather  than  being  increased  in  cerebral  malaria,  NO  pro- 
duction  is  inversely  proportional  to  disease  severity.  We 
demonstrate  in humans  an in vivo correlation between in- 
creased  NO  production  and  protection  from  a  human 
pathogen,  as well as decreased NO  production  and severity 
of clinical infection. 
Materials and Methods 
Patients.  This  study  was  performed  at  Muhimbili  Medical 
Centre (MMC), Dares Salaam, Tanzania, from May 1994 to Jan- 
uary  1995.  The protocol was approved by the College Research 
and  Publications  Committee at MMC  and  the Institutional Re- 
view Board at Duke University Medical Center.  Informed con- 
sent  was  obtained  in  Kiswahili from  all parents  or guardians  of 
study  children.  Five groups  of children  6  mo  to  9  yr old were 
prospectively recruited from the pediatric and surgical wards:  (a) 
healthy controls (HC), had no fever within the last 2 wk, no par- 
asites  on thick blood film, normal white cell count, and no acute 
illness (fracture older than  1 wk permitted); (b) asymptomatic par- 
asitemia  (AP)  was  defined as per healthy control,  except for the 
presence of P. falcipamm  parasitemia on thick blood film; (c) un- 
complicated clinical malaria  (UM) was defined as a febrile illness 
with P. falcipamm parasitemia of/> 10,000 trophozoites/Ixl, no his- 
tory  of convulsions,  no  other evident cause  of fever, fully alert, 
normoglycemic, and  without severe respiratory  distress;  (d)  CM 
with  complete  recovery  (CMC1L)  was  defined  as  unarousable 
coma  (2)  with  a  Blantyre  coma  score  (19)  of ~<2  persisting  for 
>130 min after the last convulsion, no other cause of coma evident 
from clinical or CSF analysis,  any level of P. falcipamm parasitemia 
on thick film examination, and recovery without neurological se- 
quelae;  and  (5)  CM  complicated  by  death  or  neurological  se- 
quelae (CMDS) was defined as for CMCR, but with coma com- 
plicated by death  or neurological sequelae on discharge.  Patients 
with malaria were managed according to standard  MMC guide- 
lines. 
Dietary Control.  Exogenous dietary nitrate ingestion can con- 
tribute significantly to urine and plasma nitrate levels (20,  21).  A 
protocol  using  a  low  nitrate  dinner  plus  an  overnight  fast,  fol- 
lowed by fasting morning spot urine collections for nitrate/creat- 
inine measurement,  gives results comparable to 24-h  urine sam- 
ples collected after 1-2 d of a low nitrate diet (21).  We therefore 
used this method of dietary control in children in the HC and AP 
groups.  Few of the commonly eaten local foods in Tanzania are 
high  in  nitrate  (22).  For their evening meat,  subjects  consumed 
their  usual  hospital  diet and  were  then  asked  to  fast  overnight. 
Nitrate-free distilled water was  provided with  the  evening meal 
and  for overnight use.  The  morning after an  overnight fast,  the 
first  urine  specimen  was  discarded.  After a  distilled water  chal- 
lenge, the second fasting morning urine and  venous blood were 
obtained.  A  24-h  dietary  history of the previous day's food and 
fluid intake was also documented. 
To  confirm the  adequacy  of the  control subject's  dietary  ni- 
trate restriction, we placed a subset of 18 HC and AP children on 
a  supervised standardized  low nitrate  diet  (distilled water,  white 
bread,  baked  chicken,  and white rice cooked in  distilled water) 
for 24 h. Urine samples were collected after a ward evening meal 
and overnight fast as described above, as well as after a 24-h low 
nitrate diet and a second overnight fast. The time since ingestion 
of last  food  and  drink  was  documented  in  the  UM  and  CM 
groups at the time of recruitment. 
Sample Collection.  Venous blood was obtained in EDTA and 
lithium heparin anticoagulant. Hemoglobin and white cell counts 
were measured using a Coulter counter.  Thick blood films were 
stained using Field's stains A and B. Thin blood films were stained 
using Giemsa stain. Numbers of parasites per 200 white cells were 
counted  from  thick  films.  Parasitemia  (per  milliliter  of whole 
blood) was then calculated from the automated white cell count. 
50  oil in~nersion  fields  were  examined  by  an  experienced  mi- 
croscopist before a fihn was classified as negative. Urine was col- 
lected  into  isopropanol  to  prevent  bacterial  nitrate  reduction. 
Plasma was aspirated from 3-4 ml of whole blood in lithium hep- 
arin  anticoagulant  within  30  rain  of collection  and  frozen  at 
-70~  Mononuclear cells were then separated by centrifugation 
over Ficoll/Hypaque (Lymphocyte Separation medium; Organon 
Technica,  Durham,  NC) and stored in liquid nitrogen  until use. 
For logistical reasons, blood mononuclear cells could only be col- 
lected from those subjects recruited in the latter part of the study. 
Nitrate and Nitrite Quantitation.  Concentrations  of nitrate  and 
nitrite were measured by capillary electrophoresis of plasma ultra- 
filtrate, using a  modification of the method of Leone and  Kehn 
(23).  Nitrate and nitrite concentrations were" added and expressed 
as total NOx.  The final concentration of NO~ was corrected for 
trace  amounts  of nitrate  and  nitrite  in the filter units  and  blood 
collection tubes,  determined  by capillary electrophoresis.  Plasma 
creatinine  was  measured  using an  Ektachem  autoanalyzer  (East- 
man Kodak Co., Rochester, NY). Because 60-73% of plasma ni- 
trate  is  excreted  renally  (17,  24),  nitrate  is  retained  and  plasma 
NO~  elevated  in  otherwise  healthy  humans  with  renal  impair- 
ment (25).  Plasma NO~ was therefore corrected for renal disfunc- 
tion and expressed as plasma NOJcreatinine (Cr) ratio. 
Urine  NOx  (uNO~)  was  measured  at a  1:19.3  dilution  using 
Pseudomonas oleovorans nitrate  reductase  coupled  with  the  Griess 
reaction,  as described by Granger et al.  (26).  The possibility that 
urine at a  1:19.3  dilution inhibits bacterial nitrate  reductase  was 
excluded by  running  a  standard  curve  in  the  20  CM  and  UM 
urine samples that had the lowest NOx concentrations. There was 
complete  detection  of added  nitrate  to  100  I~M  in  19  of 20 
urines.  Because  of some variability of urine  concentration,  spot 
samples were nonnalized, expressing nitrate concentration as a func- 
tion  of creatinine  concentration  (Sigma  Diagnostics,  St.  Louis, 
MO). Fractional excretion of NO￿  (FENox), the percentage of fil- 
tered  NO~  that  is  excreted,  was  calculated  by  the  formula: 
FENOx =  100  ￿  (U/P NO,)/(U/P creatinine). 
Cytokine Measurement.  Human 1L-10,  TNF-cr  and IL-4 were 
measured  with  commercial  reagents  using  standard  sandwich 
ELISAs, as described previously (27).  The capture/detecting bio- 
tinylated antibody pairs used were mAb-5817508/mAb-5817503 
(Medgenix, Stillwater, MN) for TNF, mAb-M010/mAb-M-011 
(Endogen,  Inc.,  Boston,  MA)  for  IL-10  and  polyclonal  Ab-P- 
451/  mAb-M450-B  (Endogen)  for IL-4.  Assay  sensitivities were 
4.7 pg/ml for IL-10,  15.6 pg/ml for TNF, and 3.1  pg/ml for IL-4, 
respectively. Recombinant standards  used for TNF, IL-10, and IL-4 
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coh)-5817510  (Medgenix),  and  rhlL-4  (E.  colO-R-IL4-5  (En- 
dogen). 
NOS2 lmmunoblot Analysis of PBMC Extracts.  Cellular  extracts 
were prepared  and analyzed for NOS2 antigen content by immu- 
noblot, as previously described  (28). Immunoblots were done us- 
ing a monoclonal anti-NOS2 antibody (Transduction Laborato- 
ries,  Lexington,  KY;  28)  and  ECL  reagents  from  Amersham 
(Arlington Heights,  IL). For known negative and positive ex- 
tracts, we used untreated cells from the murine macrophage cell 
line J774, and J774 cells and cells from the human colon cell line 
DLD1  treated  with rlFN-y (200 U/m1; murine for J774 cells and 
human for DLD1  cells) and LPS (200 ng/ml) for 3 d. 50 b~g pro- 
tein from the human and murine cells was used in the individual 
lanes.  An imnmnoblot for  NOS2  was  considered positive if a 
clear band was visible at 130-131  kD. To quantitate NOS2 anti- 
gen, immunoblot band density was measured using a densitome- 
ter (Molecular Dynamics, Inc., Sunnyvale, CA). 
Statistical Analyses.  A general linear models approach  (29) was 
used to model the relationship  between markers of NO produc- 
tion and disease severity controlling for suspected covariates. Log 
transformations  of the  dependent variables were  used  to  obtain 
normally distributed model residuals. Since there was little difference 
between the CMCR and CMDS groups, these groups were com- 
bined as a single CM group. Age,  sex, h  since  last fed,  chloro- 
quine intake,  parasite  count,  henmglobin, and  (in the  case of 
plasma NO~ levels and urinary NO￿  ratio)  the plasma 
creatinine  level,  were examined for covariance.  The model that 
included all significant parameters  was considered the "best" fit. 
Post-hoc disease category pairwise comparisons were done using a 
least squares means (LSM) approach  (29). For each t test, signifi- 
cance was evaluated  using a Bonferroni adjustment for nmltiple 
comparisons  (i.e., a!i =  0.05/6  =  0.0083  for each H{,: LSM [i] = 
LSM~]),  Pairwise  comparisons  of the differences between NO￿ 
creatinine ratios performed on consecutive days were performed 
using the Wilcoxon Rank Sum test. Differences among groups in 
the proportion with detectable  PBMC NOS2 were assessed by 
chi-square  analysis  followed  by  pairwise  comparisons  using 
Fisher's  exact  test  (significance set at P  <0.0083).  The relation- 
ship between cytokine levels and disease severity  was measured 
using the Kruskal-Wallis  test followed by pairwise Mann-Whit- 
ney U tests. For this analysis, the HC and AP groups were com- 
bined. For statistical purposes,  cytokine levels below the sensitiv- 
ity of the assay were assigned a value of half the lower limit of 
detection. 
Results 
Subjects.  There were 191  children in the study popula- 
tion. Mean age and weight, and sex distribution were simi- 
lar for each study group  (Table  1).  Of the  50  children in 
the diet-controlled groups (HC and AP), 29 (22 HC, 7 AP) 
were healthy children awaiting elective surgery for nonin- 
flammatory and nonmalignant disorders (mostly talipes and 
cleft lip repairs) or their resident siblings, and 21  (18 HC, 3 
AP)  were  receiving bed rest for  a  fractured long bone of 
greater than  1-wk duration. As expected,  mean hemoglo- 
bin was inversely related to disease severity. Eight children 
with severe anemia (hemoglobin range =  3.1-5 g/dl) were 
included in the UM group. None of these eight had severe 
respiratory distress, as manifest by intercostal in&awing or 
deep  breathing.  Otherwise,  all  55  children  in  the  UM 
group had uncomplicated malaria as defined by The World 
Health  Organization  (WHO;  2).  No  children with  UM 
died.  The  CM  groups  included >90%  of children with 
WHO-defined CM  admitted to  MMC  during the  study 
period.  Of the 36 children in the  CMDS  group, 26  died, 
Table 1.  Baseline Characteristics  qf Study Groups 
Characteristic  HC  AP  UM  CMCR  CMDS 
Number*  40  10  55  50  36 
Mean age (years)  4.1  5.1  3.1  3.6  3.4 
(range)  (0.5-9.6)  (0.7-8.4)  (0.5-7.8)  (0.6-7.2)  (0.7-7.2) 
Mean weight (kg)  13.8  14.4  12.0  12.4  12.5 
Median time since admission (h)  n.a.  n.a.  7.0  5.0  3.5 
Mean time since last food (h)  13.0  13.0  5.6  16.2  17.7 
Mean time since last fluid (h)*  12.4  11.3  2.6  12.4  15.8 
Chtoroquine use in preceding week (%)  5  0  53  92  86 
Sex (% male)  65%  60%  51%  44%  61% 
Geometric mean parasitemia (trophs/gl)  0  595  45,624  23,963  44,691 
Mean Hb (g/dL)5  l 1.2  9.2  7.3  6.4  6.3 
Mean white cell count (X 109/liter)~l  8,5  9.6  11.2  12.7  19.7 
*Urine obtained in all but 2 of the UM group; number with plasma obtained: HC, 34; AP, 9; UM, 53; CMCR, 43; CMDS, 28. 
*Does not include distilled  water ingested by HC and AP groups. 
~Number for each group: HC, 35; AP, 9; UM, 55; CMCP,, 48; CMDS, 31; normal range for hemoglobin (Hb) 6-23 mo of age, 10.5-13.Sg/dL; 
2-6 yr, 11.5-13.5 g/dL; 6-10 yr, 11.5-15.5 g/dL. 
￿82  for each group: HC, 35; AP, 9; UM, 52; CMCR, 48; CMDS, 3l. 
Normal range for white blood cells 6 too-2 yr of age: 6.0-17.5 ￿  10'7liter; 3-6 yr: 5-15.5 ￿  10')/liters;  7-10 yr: 4.5-13.5 ￿  10'Vliter. 
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Figure 1.  Urinary  NO~ excretion in each study group. Data are ex- 
pressed as urine NO~/cr ratios (IxM/btM, means -+ SEM) on a logarith- 
mic scale. Study groups are fasting HC  (n =  40), fasting AP (n =  I0), 
UM (n =  53), CMCP, (n =  50), and CMDS (n =  36). The adjusted 
means for both the HC and AP groups differed significantly  from each of 
the UM and CM groups (P =  0.0001). After Bonferroni adjustment  for 
multiple comparisons, there was no significant  difference in the adjusted 
means between the UM and CM groups (P =  0.216), or between the 










1  ~ 
0.0 
o  o 
~176  !t  o  ~ 
8 
o 
~  ~  o 
0 
o 
'  t  8  e 
~ 
,  ,  ,  .  . 
HC  AP  UM  C  CR  C  DS 
Study Group 
Figure 2.  Plasma NO~ corrected for renal impairment. Data are ex- 
pressed as plasma NOjcr ratios (p,M/liM, means + SEM). Study groups 
are [~sting  HC (n = 34), fasting  AP (n = 9), UM (n = 53), CMCla, (n = 
43), and CMDS (n = 28). All disease category-adjusted  means were sig- 
nificantly  different  from all others: HC vs. AP (P = 0.0008), HC and AP 
vs. UM and CM (P = 0.0001), and UM vs. CM (P = 0.0003). 
giving an overall mortality rate for CM in this series of 30% 
(26 of 86). Neurological sequelae occurred in 10 of the 86 
children with CM  (12%),  including 9  with cortical blind- 
ness  and  5  with  spastic  quadriparesis.  Convulsions were 
witnessed after admission in 77 and 72% of children in the 
CMCt< and CMDS groups, respectively. 
Urine and Plasma Nitrite and Nitrate Levels.  Urinary  nitrate 
excretion decreased in proportion to disease severity, being 
highest  in  those  children with  asymptomatic  parasitemia 
and lowest in the  CMDS group  (Fig.  1).  The best model 
fitting the relationship between the uNOJcr  ratio and dis- 
ease  severity was the one that controlled for the covariates 
age,  parasite  count,  and plasma  creatinine (P  =  0.0001), 
This model explained 50.3% of the overall variation in the 
uNOx/cr.  Nitrate  excretion  in  both  the  UM  and  CM 
groups was significantly lower than in each of the HC and 
AP groups (P =  0.0001 for each comparison; Fig. 1). 
Differences in mean plasma NO￿  with (Fig, 2) and with- 
out (Table 2) correction for renal impairment paralleled the 
urine  NO~  excretion  results.  Corrected  and  uncorrected 
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plasma NOx were highest in the  AP group and lowest in 
the CM groups. The best model fitting the relationship be- 
tween plasma NOx  and disease severity was  the  one  that 
controlled for the  covariates age,  hours since fed,  and the 
logarithm of creatinine (P  =  0.0001).  Relative to  healthy 
controls,  the  least squares  mean plasma  NO~  was  signifi- 
cantly lower in those with UM (P =  0.0007) and CM (P = 
0.0001).  The AP least squares mean plasma NO￿  was sig- 
nificantly higher  than  in each  of the  HC  (P  =  0.0018), 
UM (P =  0.0001), and CM (P =  0.0001) groups (Table 2). 
Plasma levels of nitrite, the NO metabolite least influenced 
by diet (22), paralleled those of total NO￿  (Table 2). 
The best model fitting the  relationship between plasma 
NOx/cr  ratio  and  disease  severity was  the  one  that  con- 
trolled  for  age  as  the  only  significant  covariate  (P  = 
0.0001). This model explained 43.7% of the total variation 
in the plasma NOx/cr ratio. Relative to HC, mean plasma 
NOJcr  was higher in those with AP and lower in those 
with UM  and CM  (Fig.  2).  All disease  category-adjusted 
means were significantly different from all others  (HC vs. Table 2.  Plasma  NO Metabolite Concentrations and Renal Function in Each Study Group 
Characteristic  HC  AP  UM  CMCIK  CMDS 





mean (~mol/liter) (range) 
Proportion having elevated plasma 
creatinine for age* (%) 
Plasma NOx corrected for renal impairment 
(NOx/cr ratio) mean (~M/~M)  +  SEM*II 
FENox 
30.8 +  3.7  48.4 -  7.4  25.5  +  2.4  21.9  •  1.6  29.0 +  3.9 
8.8 •  0.6  9.4 +  1.1  5.8 •  0.3  6.6 _+ 0.4  7.5 --+ 0.7 
39.6 +  3.9  57.8 +  7.3  31.3 •  2.4  28.5  •  1.6  36.5 +-- 4.1 
34.8  32.0  36.9  51.8  69.1 
(26-53)  (26-44)  (26-44)  (26-159)  (35-159) 
0  0  0  21%  39% 
1.18 +  0.12  1.84 +  0.26  0.88 --+ 0.07  0.62 +  0.04  0.60 +  0.06 
31%  31%  25%  24%  21% 
*Number with plasma obtained: HC, 34; AP, 9; UM, 53; CMC1K, 43; CMDS 28. 
~;Normal range for plasma creatinine increases with age (30). 
~The least squares mean plasma NOx for the HC group differed significantly from those of the AP (P = 0.0018), UM, (P =  0.0007) and CM groups 
(P =  0.001). The AP least squares mean differed from that of both the UM and CM groups (P =  0.0001). After Bonferroni adjustment for multiple 
comparisons, the UM least squares mean was not significantly different from that of the CM group (P =  0.0482). 
￿82  squares mean plasma NOx/cr ratios in all study groups were significantly different from all others: HC vs. AP (P =  0.0008), HC and AP vs. 
UM and CM (P =  0.0001), and UM vs. CM (P =  0.0003). 
AP  [P  =  0.0008],  HC  and  AP  vs.  UM  and  CM  [P  = 
0.0001], and UM vs. CM  [P =  0.0003]). 
Uncorrected  plasma  NO~  levels  were  higher  in  the 
CMDS  group  relative  to  those  in  the  CMCR  and  UM 
groups. However, even without correcting for renal impair- 
ment,  plasma  NO x  levels  in  CMDS  were  not  elevated 
above the basal levels found in fasting health  3, controls. IKe- 
nal impairment, as evidenced by elevated plasma creatinine 
for age (30), was found only in children with CM (Table 2). 
After correction for renal impairment, mean plasma NOx/cr 
in the CMDS group was the lowest of all groups. This sug- 
gests that  impaired nitrate  excretion rather  than  increased 
NO  synthesis was  the  reason  for the  relative elevation of 
uncorrected plasma NOx in CMDS. 
The  fractional excretion of NOx  (the  proportion of fil- 
tered  NOx  that  is  excreted)  was  decreased  in  those  with 
CM,  being lowest in the CMDS  group  (Table 2).  There- 
fore,  in CM,  not  only was  glomerular filtration of nitrate 
reduced  (as  measured by increased plasma creatinine), but 
the  filtered  nitrate  was  more  avidly reabsorbed.  Both  of 
these factors acted to elevate plasma NOx levels in the CM 
group.  Despite  this,  mean  plasma levels of NOx  in  CM 
were still lower than in HC. 
Dietary histories from children in the HC and AP groups 
confirmed the intake of low nitrate foods  (22,  31)  for the 
evening  meal  before  the  overnight  fast:  74%  consumed 
brown beans, rice, and/or maize porridge, 16% fresh meat 
and rice,  8%  chicken and  rice, and  2% breast milk alone. 
Local  foods  potentially high  in  nitrate  (spinach  and  cab- 
bage)  (22,  31)  were  eaten by only 3  of 50  children (all in 
the  HC  group).  The  mean  fasting NOx/cr  ratio  in  urine 
samples obtained the next morning in these three children 
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was 0.28, no higher than the group mean of 0.39. The only 
other vegetables consumed were the low nitrate vegetables 
potato  (n  =  2)  and  cassava  (n  =  2).  Noncured  fish  was 
eaten by four children  (three  HC,  one  AP)  with  a  mean 
fasting NOx/cr  ratio the  next morning of 0.27,  again less 
than  the  HC  group  mean.  We  confirmed  that  the  ward 
evening meal was low in NOx. In 18 children from the HC 
and  AP  groups,  the  mean  fasting urine  NOx/cr  ratio  the 
morning after a normal ward evening meal (0.368)  did not 
fall further after a standardized 24-h low nitrate diet (0.347; 
P  =  0.97). Likewise, groundwater ingestion was not a con- 
founding factor.  NOx  concentrations  in  all samples taken 
from bedside water containers of 15 HC children were low 
(mean  --  1.4 ~xM). Water samples drawn from five widely 
separated locations in Dares Salaam was also relatively low 
in NOx (mean =  10.9  ~M [range =  8.1-12.9  ~M]). 
Chloroquine (to 5 p,g/ml) has no effect on NOS activity 
in vitro (Hibbs, J.B., Jr., personal communication). Differ- 
ences  in  previous  chloroquine  ingestion among  the  study 
groups  (Table  1)  did not  influence  urine  or plasma NOx 
when analyzed using linear modeling. There was no  effect 
of a  treatment  course  of chloroquine  (10  mg/kg  then  5 
mg/kg,  44  and  52  h  after commencing a low nitrate diet) 
on basal urine nitrate excretion in a  group  of five healthy 
adult volunteers.  Mean  fasting  NOx/creatinine  ratios be- 
fore and after chloroquine ingestion were 0.039 and 0.041, 
respectively (P -  0.51).  There  was  no  difference in NOx 
levels between  those  children in  the  HC  group  with  and 
without a long bone fracture, nor in the UM group with or 
without severe anemia. 
Leukocyte NOS2 Antigen Content.  To  determine if leu- 
kocyte NOS2  was  also modified in malaria, we measured Figure  3.  (A)  lmmunoblot  analysis  of 
mononuclear  cells  from  study  subjects  for 
NOS2 expression.  Blood mononuclear cells 
were isolated, and extracts were analyzed for 
NOS2  antigen  content  using  an  NOS2 
mouse  monoclonal  anti-NOS2  antibody. 
The NOS2 antigen has a molecular mass of 
~130  kD.  Extracts  from  the  nmrine mac- 
rophage cell line J774 and human colon cell 
line DLI)I  were used  as negative and posi- 
tive controls.  50 Ixg of protein from the ex- 
tracts were used  in each  lane.  lnnnunoblots 
using  isowpe-matched  (IgG2a)  control  lg 
showed no reactivity.  Only I  of 18 CM pa- 
tients  was  positive.  In  contrast,  15  of  15 
healthy controls  and  7  of 7  children with 
asymptomatic  parasitemia  showed  a  clear 
band at  130-131  kD.  5 of 14 patients  with 
uncomplicated malaria  were positive (four- 
group chi square:  P <O.O00l).  The HC and 
AP  groups  each  differed  significantly  from 
the CM  group  (P <0.0001  for each  com- 
parison)  and UM  group  (P  =  0.0002  and 
P  =  0.0071,  respectively).  The  difference 
between  the CM  and UM  groups  did not 
reach  statistical  significance  (P  =  0.064). 
AP1-3, samples from three children with as- 
ymptomatic  parasitemia;  HC1-3,  salnples 
from three healthy control children; CM 1-4, 
samples from four patients with cerebral ma- 
laria; J, J774 control; J+, J774 cells cultured 
with LPS and IFN-y; D +, I)LD1  cells cul- 
tured  with  LPS  and  human  IFN-y.  (/3) 
PBMC NOS2 antigen relationship  to plasma 
NOx/cr ratios.  NOS2  antigen was  quanti- 
tated  by  imnmnoblot  band  densitometry. 
J774-negative control background was sub- 
tracted,  and the results  were  expressed  as a 
percentage  of  the  l)LDl-positive  control 
density.  Mean  inmmnoblot  densities  in 
healthy controls (n =  15) and m asymptom- 
atic  parasitemia  (n  =  7)  were  significantly 
higher than in clinical malaria (UM; n =  14 
and CM;  n  =  18). By four-group Kruskal- 
Wallis testing,  P <0.0001 ; HC vs. UM: P = 
0.0058,  AP vs.  UM:  P  =  0.0012;  HC  vs. 
CM:  P  <0.0001; AP vs. CM:  P  =  0.0002. 
The differences  between HC  and AP (P = 
0.098)  and  between  UM  and  CM  (P  = 
0.17)  were  not  statistically  significant. 
PBMC NOS2 expression  was closely associ- 
ated  with  NO  production  in  each  study 
group as measured by the plasma NOx/crea- 
tinine  ratio.  Squares, inmmnoblot  density 
(mean  -+  SEM);  diamonds, plasma  NOx/cr 
ratio (btM/~M) (mean  -+ SEM). 
NOS2  antigen content by immunoblot  analysis. PBMC  ly- 
sates  from  only  1  of  18  CM  patients  (11  CMCR  and  7 
CMDS)  contained  a  protein  (130-131  kD)  that  reacted 
with  the  anti-NOS2  antibody.  In  contrast,  NOS2  antigen 
was  detected  in all  15  HC  and all 7  AP  subjects in which 
cell lysates were  tested.  5  of 14  cell lysates from UM  chil- 
dren  displayed  the  antigen  on  blot  (P  <0.0001  by  four- 
group  chi square  analysis).  Fig.  3  A  shows  a  representative 
immunoblot.  For  immunoblots  using  isotype-matched 
(IgG2a) control Ig, there was no positivity (data not shown). 
The HC  and AP groups each differed significantly from the 
CM  group  (P  <0.0001  for  each  comparison)  and  UM 
group  (P  =  0.0002  and  0.0071,  respectively).  The  differ- 
ence between  the CM  and UM  groups did not reach statis- 
tical  significance  (P  =  0.064).  Mean  immunoblot  band 
density in each group  closely paralleled plasma NOx/cr  ra- 
tios  (Fig.  3  b).  NOS2  band  density  correlated  significantly 
with plasma NO￿  ratios (R  =  0.319;  P  =  0.022). 
Plasma Cytokine Measurements.  Plasma levels of both TNF 
and IL-10  correlated with disease severity, being highest in 
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Figure  4.  (A) Plasma TNF-cr levels related to disease severity. Plasma 
levels of TNF correlated with disease  severity. Number of samples assayed 
in each group were as follows: HC/AP, 27; UM, 39; CMCR, 42; and 
CMDS, 30. Box plots show the interquartile range. Medians and means 
are indicated by horizontal lines and circles, respectively.  Vertical lines in- 
dicate the 10th-90th  percentile ranges. TNF was significantly higher in 
the CMDS group than in the CMCR (P =  0.0037), UM (P =  0.0009), 
and HC/AP (P <0.(}001) groups. TNF was undetectable in all HC and 
AP subjects. Levels in HC and AP were significantly  lower than in the 
UM,  CMCR,  and  CMDS  groups (P <0.000l  for  each comparison). 
There was no significant difference between the UM and CMCR groups 
(P = 0.71). (B) Plasma IL-10 levels related to disease  severity. Plasma lev- 
els of IL-10 (pg/ml) correlated with disease severity. Number of samples 
assayed in each group were as follows: HC/AP, 27; UM, 39; CMCR, 42; 
and CMDS,  30.  Box plots show the  interquartile range. Medians and 
means are indicated by horizontal lines and circles, respectively. Vertical 
lines indicate the 10th-90th  percentile ranges. Plasma IL-10 levels were 
higher in the combined CM group than in the HC/AP (P <0.0001) and 
UM  (P  =  0.032)  groups, and  higher  in  the  UM  vs.  HC/AP  group 
(P <0.0001). 
those with fatal malaria (Fig. 4, A  and B). TNF was signifi- 
cantly higher in the CMDS  group  than the CMCR  (P = 
0.0037),  UM  (P  =  0.0009),  and  HC/AP  (P  <0.0001) 
groups.  TNF was undetectable in all HC  and AP subjects, 
with levels significantly lower than in all the UM, CMCR, 
and  CMDS  groups  (P  <0.0001  for  each  comparison). 
Plasma IL-10 levels were higher in the combined CM group 
than  in  the  HC/AP  (P  <0.0001)  and  UM  (P  =  0.032) 
groups,  and  higher  in  the  UM  vs.  HC/AP  group  (P 
<0.0001).  Plasma IL-4 was undetectable in all CM samples 
tested (n =  14) and in all but one of the HC samples tested 
(,  =  12). 
Discussion 
Levels of NO  metabolites and leukocyte NOS2  expres- 
sion were decreased in both UM  and CM,  indicating sup- 
pression of NO  synthesis rather than excessive production 
in clinical malaria in children. The suppression of NO  syn- 
thesis increased with disease severity. The  known  in vitro 
antiplasmodial  effects  of  endogenous  NO-related  com- 
pounds  suggest an in vivo protective role for NOS  in ma- 
laria. IFN-',/ and the parasite itself inhibit the development 
of the exoerythrocytic stage of the plasmodium species via 
the  induction  of  NO  within  both  murine  and  human 
hepatocytes (12,  13,  32,  33).  Human  monocytes have also 
been shown to inhibit erythrocytic stages of P. fakiparum in 
vitro via secretion of nitrogen oxides  (14).  Suppression of 
NO-mediated protective immune  responses after infection 
with P.falciparum may result in inadequate control of para- 
site replication, and may have contributed to the develop- 
ment of clinical malaria and CM in these children. 
A  protective  role  for  NO-related  activity in  malaria is 
also supported by our finding that leukocyte NOS2 antigen 
and NO  metabolite levels were highest in those with infec- 
tion but no disease. Enhanced NO  synthesis may have pro- 
tected  these  children  with  low  grade  AP  from  clinically 
overt  disease.  However,  longitudinal studies  of host  NO 
production will be required for final analysis. It was striking 
to  observe  the  universal  expression  of NOS2  antigen  in 
heahhy  control subjects.  NOS2  expression in  freshly iso- 
lated blood leukocytes of normal adults in the United States 
is rare (28,  28a).  Possible explanations for our observations 
in cells from HC Tanzanian children include physiological 
high  expression  in  childhood,  genetic/racial  differences, 
and subclinical or subpatent infection with malaria or other 
pathogens. 
Several reports have described plasma NO￿  levels in hu- 
man malaria (34-38).  It is difficult to extrapolate NO  pro- 
duction from the NOx levels measured in these studies be- 
cause of absent or insufficient numbers  of control subjects, 
inadequate control for the potential confounding effects of 
dietary nitrate  ingestion,  and  lack of correction  for  renal 
impairment, altered FENo￿  and altered volume of distribu- 
tion of NOx in severe malaria. 
Despite the close correlation between leukocyte NOS2 
antigen  levels  and  plasma  NOx/cr  ratios  in  the  different 
groups,  we  considered potential artifacts that  would  have 
influenced the NOx results. Our NO x results cannot be ex- 
plained  by  differences  in  nitrate/nitrite  (NO~)  ingestion 
among the study groups.  The Dar es Salaam water supply, 
particularly at the  study site, was  low in NO x.  The  staple 
Tanzanian  foods  of rice,  beans,  and  maize  are  all low  in 
NOx (22). The approach to dietary control in the HC  and 
AP  groups  used  in  this  study  adequately  excludes  a  con- 
founding  effect  of dietary  NO x ingestion  (21).  Since  the 
half life of nitrate after an oral nitrate load is 6--7 h  (39), di- 
etary nitrate would have been largely cleared in subjects in 
the  HC,  AP,  and  CM  groups  whose  mean  durations  of 
fasting were two nitrate half lives or longer. NOx excretion 
and plasma NO~ were less in the UM  group, despite more 
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group, and lower still in the CM groups despite compara- 
ble duration of fasting.  It is theoretically possible that in se- 
vere malaria, compared with controls, a greater proportion 
of NO is metabolized via an as-yet unknown  pathway to 
non-nitrate/nitrite  end products.  If true,  measurement of 
NO~  would  underestimate  NO  production.  There  is  no 
evidence to date to support this notion, and this too would 
not  account  for the  difference  between  the  HC  and  AP 
groups. 
Differences in renal nitrate excretion did not explain the 
differences in plasma or urinary NO, levels among those in 
the  HC, AP,  and UM groups.  Renal insufficiency caused 
higher plasma NO~ levels in the CMDS group than in the 
CMCR  group  (although  not  statistically significantly so). 
This difference disappeared once levels were corrected for 
renal impairment. If we had not analyzed a control group 
and corrected for renal impairment (25,  40, 41), this differ- 
ence might have been incorrectly interpreted as  increased 
NO synthesis in complicated vs.  uncomplicated CM.  Be- 
cause the volume of distribution ofNO~ (VaNOx) approx- 
imates  extraceUular fluid volume  (41),  plasma  NOx levels 
will be increased and NO formation will be overestimated 
in disease  states characterized by extracellular fluid volume 
contraction. As others (42),  we commonly observed dehy- 
dration  in  children  with  CM  in  this  study.  It is  therefore 
likely  that  the  V,tNO~  was  reduced  in  the  CMDS  and 
CMCR groups, and that NO formation was overestimated 
in  these  groups.  NO  synthesis in  cm  may thus  be  even 
lower than we have calculated. 
As others  (5,  6,  43,  44)  we have shown increased pro- 
duction in malaria of both the proinflammatory Thl  cyto- 
kine TNF and the atatiinflammatory Th2 cytokine, IL-10. 
Levels of both  cytokines  correlated with  disease  severity. 
Decreased  NOS2  expression  and  NO  production  in  ma- 
laria could be caused by IL-10 (45-47) and other host Th2 
cytokine  responses.  TGF-~  also  suppresses  NO  synthesis 
(48).  TGF-13 production  in semiimmune African children 
with severe malaria is not yet known.  We did not measure 
TGF-JB in  our plasma samples because of possible platelet 
contamination. 
In addition  to  host factors,  parasite t~ictors may also  be 
involved in modulating NO production after infection.  P. 
falciparum-infected erythrocytes exhibit NO synthase activ- 
ity  (49).  Parasite-derived  products  have  been  shown  to 
both increase (49,  50)  and decrease (51) NO production in 
vitro. Other intracellular protozoa such as Leishmania major 
are able to directly increase host TGF-~ production, result- 
ing in suppression of NOS2 expression and parasite survival 
(32).  Strains of P.falciparum are known to vary in their abil- 
ity  to  induce  TNF  production  by  human  mononuclear 
cells,  with  some  relationship  to  disease  phenotype  in  the 
host (52).  It is possible there is a similar strain heterogeneity 
in  the  ability  to  produce  parasite  NOS,  or  to  induce  or 
suppress human NOS2. 
Suppression  of NO  production  in  clinical  malaria  and 
CM may have deleterious effects other than a possible im- 
paired ability to suppress parasite development. TNF~x, IL-1, 
and  other  proinflammatory  cytokines  are  known  to  in- 
crease a number of human endothelial molecules involved 
in parasite cytoadherence and sequestration (e.g., ICAM-l, 
VCAM-1,  and E-selectin [53-56]).  NO decreases this en- 
dothelial  activation.  In  human  vascular  endothelial  cells, 
cytokine-induced expression of adhesion molecules such as 
VCAM-I,  E-selectin,  and to a lesser extent,  ICAM-I  are 
all  decreased by exogenous  and  endogenous  NO  (56)  via 
inhibition of NF-KB (57).  We speculate that decreased NO 
synthesis in malaria could thus cause loss of  endothelial NF-v,,B 
inhibition,  resulting in increased  expression of endothelial 
adhesion molecules, increased parasite sequestration,  and a 
greater likelihood of developing CM. Moreover, decreased 
NO production may also  result in increased production of 
TNF.  In rats,  inhibition  of NOS  before endotoxemia  re- 
sults  in a significant increase in circulating TNF and IL-6, 
and increased mortality (58).  Inhibition of NO synthesis in 
malaria  may  thus  cause  a  greater  increase  in  circulating 
TNF and further upregulation of endothelial  receptors re- 
volved in parasite sequestration. 
Some have hypothesized that there is local upregulation 
of NOS2  activity m  cerebrovascular endothelium,  or that 
excessive  local  NO  synthesis  contributes  to  the  coma  of 
CM  (15).  However,  based  on  our  evidence  for systemic 
suppression of NO synthesis in pediatric CM, we think that 
this is unlikely. Nevertheless, this cannot be excluded with- 
out doing detailed studies of brain specimens for NOS con- 
tent and  activity.  Postmortem examination of brain  tissue 
was not culturally or logistically possible in our study. 
The  mortality rate  from CM  remains  1(I-30%,  despite 
prompt administration  of the  best available chemotherapy 
(42),  and better therapies for treating CM are needed.  NO 
synthesis appears to be suppressed in  CM  in African chil- 
dren,  but  the  therapeutic  implications  of this  require  fur- 
ther study. Potential benefits of NO donors include the in- 
hibition  of parasite  development  (59)  and  a  decrease  m 
parasite cytoadherence (56), the process central to the patho- 
genesis  of CM  (60).  Increased cerebral blood volume  has 
been  implicated  in  the  pathogenesis  of raised  intracranial 
pressure  in  African  children  with  CM  (61,  62).  It is  not 
certain what effect NO donors may have on this process. 
Because  the  pattern  of disease  phenotype  and  immune 
response varies with age and intensity of malaria transmission 
(63,  64), the role of NO in malaria needs to be determined 
in adult and pediatric populations from regions with differ- 
ent malarial epidemiology. Results from our study of Aft-i- 
can  children  in  this  region  of moderately  intense,  stable 
malaria transmission demonstrate that NO production and 
NOS2 expression correlate with protective rather than dis- 
ease-producing  responses  in  malaria  infection.  We  docu- 
ment  an  in  vivo correlation  between  increased  NO  pro- 
duction/NOS2  expression  and  suppression  of  a  human 
pathogen,  as well as a correlation between decreased NO 
production/NOS2 expression and disease  severity. 
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